Save the Date

November 13 – 14, 2019 • Harvard Medical School, Boston, MA

Organizing Committee

The 15th Annual Personalized Medicine Conference is being organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.


Chair

EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition

Bonnie J. Addario
Founder, Chair, Bonnie J. Addario Lung Cancer Foundation; lung cancer survivor

Mary Bordoni
Director, Alliance Development, Biotechnology Innovation Organization

Alex J. Carlisle, Ph.D.
Chairman, CEO, National Alliance Against Disparities in Patient Health

William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen

Julia Drake
International Product Manager, Genentech

Stephen L. Eck, M.D., Ph.D.
Chief Medical Officer, Immatics US

Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator

Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare

Dan Leonard
President, National Pharmaceutical Council

Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Precision Medicine, Novartis

Susan McClure
Founder, Publisher, Genome magazine

Howard McLeod, Pharm.D.
Medical Director, DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center

Tom Miller
Founder, Managing Partner, GreyBird Ventures LLC

Cynthia Casson Morton, Ph.D.
William Lambert Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Lincoln Nadauld, M.D., Ph.D.
Executive Director, Precision Medicine and Precision Genomics, Intermountain Healthcare

Joshua Ofman, M.D.
Senior Vice President, Global Value, Access and Policy, Amgen

Michael J. Pellini, M.D.
Managing Partner, Section 32

Kimberly Popovits
Chairman of the Board, CEO, President, Genomic Health

Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Worldwide Research & Development, Pfizer

Michael Sherman, M.D.
Chief Medical Officer, Senior Vice President, Harvard Pilgrim Health Care

Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University

Fintan Steele
Chief Communications Officer, SomaLogic

Mark P. Stevenson
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific

Bernadette Toner
CEO, GenomeWeb

Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting

Werner Verbiest
Global Head, Janssen Diagnostics, Johnson & Johnson

Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics